ReviewRevista medica del Instituto Mexicano del Seguro Social2024
[Human platelet antigen: brief review of the topic and its clinical significance].
Review in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platelet antigens are essential cellular components in the coagulation cascade and the immune response. Platelets are small anucleate cellular-fragments, measuring 2 to 3 μm, resulting from the fragmentation of megakaryocyte cytoplasm. Their role in hemostasis involves clot formation to halt bleeding in case of vascular injuries. Platelet antigens are proteins found on the surface of these cell fragments, participating in interactions with other blood cells and the immune response. Genetic variability and individual differences in antigens have led to the discovery of various antigen systems, such as the HLA (human leukocyte antigen) system and the ABO system. These systems influence blood compatibility in transfusions and transplants, as well as the occurrence of adverse reactions. Research in this field has proposed mechanisms related to the pathogenesis of platelet disorders and autoimmune diseases. The study of antigens has evolved with advances in genetics, molecular biology, and immunology, leading to a better understanding of their clinical relevance and impact on human health. The identification of these antigens remains crucial for improving transfusion therapies, investigating bleeding disorders, and exploring potential therapeutic targets in various diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.